Noriaki Kurimoto

Dr. Noriaki Kurimoto

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Respiratory Investigation
Verified
Journal Article
Open access
MHMegumi Hamaguchi
Megumi Hamaguchi
YTYukari Tsubata
Yukari Tsubata
ATAkari Tanino
Akari Tanino
YMYuki Mitarai
Yuki Mitarai
KHKojiro Hata
Kojiro Hata
TITakeshi Isobe
Takeshi Isobe
Some randomized controlled trials have evaluated the effects of low-dose computed tomography (CT) screening on lung cancer mortality in heavy smokers. Based on the results of those trials, our CT screening program recommended screening for people aged ≥40 years with a history of smoking. This retrospective study aimed to verify the validity of our CT screening program and elucidate the current state of CT screening program. We retrospectively examined lung cancer detection in 25,189 participants who underwent chest CT screening by a mobile low-dose CT screening unit in the 10-year period from April 2009 to March 2019. Participants were recruited at Japan Agricultural Cooperatives (JA) Shimane Kouseiren. Participants requested CT screening for lung cancer. CT images were read by two pulmonologists. Lung cancer was identified in 82 of the 25,189 participants over 10 years, an overall lung cancer detection rate (percentage of lung cancers detected among all participants) of 0.33%. Lung cancer among never smokers accounted for 54.9% of the detected cases. The lung cancer detection rate was similar for smokers versus never smokers. The stage IA detection rate (percentage of stage IA lung cancers among all lung cancers detected) was 62%, while the stage Ⅳ detection rate was 10%. Chest CT detected lung cancer in never smokers as well as current or former smokers. Our CT screening program was not effective for never smokers; thus, further study of the effectiveness of CT screening in never smokers is needed.

27 September 2022 in Respirology
Verified
Journal Article
Closed access
NKNoriaki Kurimoto
Noriaki Kurimoto

1 January 2017 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
NKNoriaki Kurimoto
Noriaki Kurimoto

30 March 2022 in Case Reports in Oncology
Verified
Journal Article
Open access
PDF file
KKKeita Kawakado
Keita Kawakado
THTakamasa Hotta
Takamasa Hotta
JSJin Sakamoto
Jin Sakamoto
MHMika Horie
Mika Horie
MHMisato Higasa
Misato Higasa
TITakeshi Isobe
Takeshi Isobe
The patient, a 62-year-old woman, complained chiefly of cough. We planned chemoradiotherapy for squamous nonsmall cell lung cancer. A single dose of 2-Gy irradiation and no anticancer agent administration exacerbated the airway stenosis with severe respiratory failure. Urgent tracheal intubation was performed, and a tracheal stent was implanted under extracorporeal membrane oxygenation (ECMO). Because her performance status (PS) worsened from 1 to 2, we administered radiotherapy. The tumor size decreased. There was no recurrence for the next 3 months, and her PS improved to 1. Emergency tracheal intubation and tracheal stent placement under ECMO can be effective for exacerbated airway obstruction after radiotherapy.

22 November 2022 in Thoracic Cancer
Verified
Journal Article
Open access
TOTakae Okuno
Takae Okuno
NKNoriaki Kurimoto
Noriaki Kurimoto
ATAkari Tanino
Akari Tanino
MHMegumi Hamaguchi
Megumi Hamaguchi
THTakamasa Hotta
Takamasa Hotta
YTYukari Tsubata
Yukari Tsubata
Background: Endocytoscopy (ECS) provides a magnification of approximately 450x for real-time observation of lesion nuclei.Using ECS, we aimed to evaluate whether sufficient samples for diagnosis can be obtained during bronchoscopy. We also investigated whether ECS can enable two-class diagnosis of malignant or non-malignant transbronchial biopsy specimens in real-time during bronchoscopy. Methods: This was a single-facility, prospective, observational, ex vivo study. Forty cases with localized peripheral pulmonary lesions underwent transbronchial biopsy with endobronchial ultrasonography using a guide sheath. Each biopsy specimen was immediately observed and evaluated endocytoscopically after the collection by the bronchoscopic procedure. Results: Thirty-seven cases were enrolled. The diagnostic accuracy achieved by ECS was 91.9% (34/37). The agreement rate between the endocytoscopic evaluation and pathological diagnosis of each specimen (170 specimens) was 65.3% (111/170). The median time required for endocytoscopic evaluation per specimen was 70 s. When we judged a specimen to be malignant a second time on ECS evaluations of five specimens in one case, pathologically malignant specimens were collected in 26 of 27 cases (96.3%). Conclusions: ECS with methylene blue staining may aid in the two-class diagnosis of malignant or non-malignant transbronchial biopsy specimens during bronchoscopy. This may reduce the number of tissue biopsies.

1 January 2020 in Respiratory Investigation
Verified
Journal Article
Closed access
THTakamasa Hotta
Takamasa Hotta
NKNoriaki Kurimoto
Noriaki Kurimoto
TOTamio Okimoto
Tamio Okimoto
YTYukari Tsubata
Yukari Tsubata
SHShunichi Hamaguchi
Shunichi Hamaguchi
TITakeshi Isobe
Takeshi Isobe